According to Agenus 's latest financial reports the company's total liabilities are $0.46 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2022-12-31 | $0.46 B | 12.06% |
2021-12-31 | $0.41 B | -1.87% |
2020-12-31 | $0.42 B | 10.17% |
2019-12-31 | $0.38 B | 24.35% |
2018-12-31 | $0.31 B | 45.15% |
2017-12-31 | $0.21 B | 9.23% |
2016-12-31 | $0.19 B | 14.35% |
2015-12-31 | $0.17 B | 232.95% |
2014-12-31 | $51.5 M | 31.01% |
2013-12-31 | $39.31 M | -15.8% |
2012-12-31 | $46.69 M | 14.9% |
2011-12-31 | $40.63 M | -10.91% |
2010-12-31 | $45.61 M | -27.42% |
2009-12-31 | $62.84 M | -22.28% |
2008-12-31 | $80.86 M | -11.72% |
2007-12-31 | $91.59 M | 1.39% |
2006-12-31 | $90.34 M | 25.04% |
2005-12-31 | $72.25 M | 171.47% |
2004-12-31 | $26.61 M | -23.6% |
2003-12-31 | $34.83 M | 208.11% |
2002-12-31 | $11.3 M | -35.84% |
2001-12-31 | $17.62 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $125.10 B | 27,074.74% | ๐บ๐ธ USA |
![]() Merck MRK | $60.89 B | 13,126.99% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | $61.45 B | 13,250.38% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $59.66 B | 12,861.70% | ๐ฌ๐ง UK |
![]() Celldex Therapeutics CLDX | $21.77 M | -95.27% | ๐บ๐ธ USA |